Page last updated: 2024-08-24

rhodamine 123 and Prostatic Neoplasms

rhodamine 123 has been researched along with Prostatic Neoplasms in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (21.43)	18.7374
1990's	8 (57.14)	18.2507
2000's	2 (14.29)	29.6817
2010's	1 (7.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anitha, A; Jayakumar, R; Lakshmanan, VK; Nair, SV; Uthaman, S	1
Jones, LW; Narayan, KS; Shapiro, CE; Sweatman, TW	1
Gassner, B; Gekle, M; Kelleher, DK; Thews, O	1
Arcadi, JA; Jones, LW; Narayan, KS; Ng, CP; Saroufeem, RM; Techy, G	1
Baumgartner, G; Hamilton, G; Schirmböck, M; Sherwood, ER; Thalhammer, T; Theyer, G	1
Futami, T; Hirao, Y; Kitagawa, H; Momose, H; Okajima, E; Ozono, S; Yoshie, T	1
Alken, P; Köhrmann, KU; Kreukler, C; Nebe, T; Siegsmund, MJ; Steidler, A	1
Arcadi, JA	3
Brazy, PC; Rago, RP; Wilding, G	1
Cheng, AL; Mitchen, J; Oberley, T; Rago, R; Wilding, G	1
Adelstein, SJ; Kassis, AI; Kinsey, BM; Van den Abbeele, AD	1
Adelstein, SJ; Fayad, F; Kassis, AI; Kinsey, BM; Layne, WW	1

Trials

1 trial(s) available for rhodamine 123 and Prostatic Neoplasms

Article	Year
Rhodamine-123: therapy for hormone refractory prostate cancer, a phase I clinical trial. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4 Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Rhodamine 123; Risk Assessment; Survival Analysis; Treatment Outcome	2005

Article

Year

Rhodamine-123: therapy for hormone refractory prostate cancer, a phase I clinical trial.

Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:4

Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Staging; Neoplasms, Hormone-Dependent; Patient Selection; Prostate-Specific Antigen; Prostatic Neoplasms; Rhodamine 123; Risk Assessment; Survival Analysis; Treatment Outcome

2005

Other Studies

13 other study(ies) available for rhodamine 123 and Prostatic Neoplasms

Article	Year
Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer. Journal of biomedical nanotechnology, 2013, Volume: 9, Issue:3 Topics: Animals; Cell Death; Cell Line, Tumor; Chitosan; Dextrans; Drug Delivery Systems; Flutamide; Humans; Light; Male; Materials Testing; Mice; Nanoparticles; Particle Size; Prostatic Neoplasms; Rhodamine 123; Scattering, Radiation; Spectroscopy, Fourier Transform Infrared; Thermogravimetry; Whole Blood Coagulation Time	2013
Activity of drug efflux transporters in tumor cells under hypoxic conditions. Advances in experimental medicine and biology, 2008, Volume: 614 Topics: Acidosis; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carcinoma; Cell Hypoxia; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Fluoresceins; Fluorescent Dyes; Isotonic Solutions; Male; Multidrug Resistance-Associated Proteins; Prostatic Neoplasms; Rats; Rhodamine 123; Ringer's Solution; Time Factors; Verapamil	2008
Studies of rhodamine-123: effect on rat prostate cancer and human prostate cancer cells in vitro. Journal of surgical oncology, 1995, Volume: 59, Issue:2 Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Cell Division; Cell Survival; Dimethyl Sulfoxide; Humans; Male; Mice; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Tumor Stem Cell Assay	1995
Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines. The Journal of urology, 1993, Volume: 150, Issue:5 Pt 1 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Division; Cyclosporine; Doxorubicin; Drug Resistance; Humans; Male; Membrane Glycoproteins; Phenotype; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Tamoxifen; Tumor Cells, Cultured; Verapamil	1993
[The effects of rhodamine 123 on the cell growth of the cultured cells derived from urogenital carcinoma]. Hinyokika kiyo. Acta urologica Japonica, 1993, Volume: 39, Issue:12 Topics: Antimetabolites, Antineoplastic; Cell Division; Humans; Male; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Urogenital Neoplasms	1993
Multidrug resistance in androgen-independent growing rat prostate carcinoma cells is mediated by P-glycoprotein. Urological research, 1997, Volume: 25, Issue:1 Topics: Androgens; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Fluorescent Dyes; Genes, MDR; Male; Methotrexate; Neoplasms, Hormone-Dependent; Paclitaxel; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine	1997
The effect of rhodamine-123 on 3 prostate tumors from the rat. The Journal of urology, 1998, Volume: 160, Issue:6 Pt 2 Topics: Animals; Drug Screening Assays, Antitumor; Male; Prostatic Neoplasms; Rats; Rats, Wistar; Rhodamine 123	1998
Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells. Cancer research, 1992, Dec-15, Volume: 52, Issue:24 Topics: Adenosine Triphosphate; Fluorescent Dyes; Humans; Male; Mitochondria; Oxygen Consumption; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Suramin; Tumor Cells, Cultured	1992
Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism. Cancer research, 1991, Dec-15, Volume: 51, Issue:24 Topics: Biological Transport; Calcium; Carcinoma; Cell Division; Energy Metabolism; Epidermal Growth Factor; Humans; In Vitro Techniques; Male; Microscopy, Electron; Mitochondria; Oxidoreductases; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Suramin; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured	1991
Use of rhodamine 123 in the treatment of the Pollard III rat prostate adenocarcinoma. Journal of surgical oncology, 1990, Volume: 44, Issue:2 Topics: Adenocarcinoma; Androgens; Animals; Male; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Xanthenes	1990
Absence of preferential uptake of [125I]iododihydrorhodamine 123 by four human tumor xenografts. Cancer research, 1989, Nov-01, Volume: 49, Issue:21 Topics: Adenocarcinoma; Animals; Cell Line; Colonic Neoplasms; Fibrosarcoma; Humans; Iodine Radioisotopes; Male; Mice; Mice, Nude; Pancreatic Neoplasms; Prostatic Neoplasms; Radioisotope Dilution Technique; Rhodamine 123; Rhodamines; Tissue Distribution; Transplantation, Heterologous; Xanthenes	1989
Synthesis and biological studies of iodinated (127/125I) derivatives of rhodamine 123. Journal of medicinal chemistry, 1987, Volume: 30, Issue:10 Topics: Adenocarcinoma; Animals; Cell Line; Cricetinae; Cricetulus; Fibroblasts; Humans; Iodine Radioisotopes; Lung; Male; Microscopy, Fluorescence; Prostatic Neoplasms; Rhodamine 123; Rhodamines; Sodium Iodide; Succinimides; Xanthenes	1987
Rhodamine-123 as effective agent in rat prostate tumor R3327-H. Preliminary report. Urology, 1986, Volume: 28, Issue:6 Topics: Adenocarcinoma; Animals; Fluorescent Dyes; Male; Neoplasm Transplantation; Prostatic Neoplasms; Rats; Rhodamine 123; Rhodamines; Xanthenes	1986